Mirai Genomics’ Post

Illumina recently introduced the MiSeq i100 series of sequencers, a compact yet powerful addition to sequencing technology that bridges the gap between accessibility and advanced capabilities. They can handle 10 to 200 million paired-end reads per run with maximum read lengths of up to 600 bp (2 x 300 bp) and a run time of 4 to 15.5 hours. Illumina's large NovaSeq X devices cost nearly $1 million. In contrast, the compact MiSeq i100 systems, suitable for benchtop use in smaller labs, cost $49,000 and enable in-house sequencing capabilities. For early-stage startups engaged in drug discovery, the MiSeq i100 can facilitate the provision of rapid, accurate multi-omics data essential for identifying target molecules and validating the efficacy of therapeutic candidates. By lowering financial barriers and simplifying operations, the MiSeq i100 series accelerates research, improves patient care, and enhances global health equity—a substantial stride towards democratizing next-generation sequencing. https://lnkd.in/g_azJFbZ

Stabilize biomolecules for ELISA, PCR, IHC, and more. Discover ambient capillary-mediated vitrification in a webinar with Upkara, AssayQuant Technologies Inc., and B2S Life Sciences. https://hubs.li/Q02vdmKM0 #assayreagents #assaydevelopment #reagentstabilization #lyophilization #moleculardiagnostics #webinar #diagnostictests

Why are Microfluidizer® processors preferred by top companies for their cell disruption needs? Our high-yield cell lysis technology is: * Easy to use and requires little maintenance * Fast to process compared to alternative methods * Efficient and results in high yields Microfluidics offers technologies to meet the variable and demanding needs for cell disruption, from gentle disruption of cultured mammalian cells to the challenging disruption of yeast and other fungi. To learn how Microfluidics is able to achieve superior cell disruption results, read our article: https://hubs.la/Q02RkdNl0 #Microfluidizer #Microfluidics #celldisruptionproduction #celllyse #cellrupture #Microfluidizerprocessors #highshearprocessors

More than half of all proteins are glycosylated, many of them at multiple sites. Did you know that already? Profiling of these glycosylation-related protein isoforms involves techniques to separate, identify, and quantify individual isoforms of glycoproteins and glycopeptides that are present in a biological specimen. Bruker's solutions, specifically the enablement of high-throughput processing empowered by the glyco-PASEF on timsTOF mass spectrometers, offer a cutting-edge approach for glycoprotein and glycan profiling. Empowering scientists with GlycoScape™ software and glyco-PASEF technology to achieve unparalleled precision in glycoprotein analysis. Follow the link for a unique opportunity to learn directly from Klaus Lindpaintner, Vice President, Glycobiology Solutions at Bruker. Key takeaways: 👩🔬 Discover how glyco-PASEF enables the precise targeting of glycopeptides, enhancing our understanding of glycoproteomics and its impact on disease mechanisms. 👨🔬 Learn about challenges in glycoproteomics and innovative solutions like GlycoScape™, which streamlines workflows by providing real-time glycoprotein identification readouts directly from your timsTOF data. #Science #Glycoproteomics #CancerResearch #timsTOF #GlycoScape #GlycoPASEF #Webinar #OnDemand #genuine #sciencecommunication

Fast and Easy Biochemistry Testing

5 Key Benefits of Aptamers in Biosensors As biosensor technologies continue to evolve, aptamers are emerging as game-changers in the field of diagnostics and molecular detection. Aptamers are revolutionizing biosensor technology—offering innovative solutions for faster, more reliable, and more efficient molecular detection. #Biosensors #Aptamers #Diagnostics #Innovation #MolecularDetection Here are five key benefits of using aptamers in biosensors:

Why are Microfluidizer® processors preferred by top companies for their cell disruption needs? Our high-yield cell lysis technology is: * Easy to use and requires little maintenance * Fast to process compared to alternative methods * Efficient and results in high yields Microfluidics offers technologies to meet the variable and demanding needs for cell disruption, from gentle disruption of cultured mammalian cells to the challenging disruption of yeast and other fungi. To learn how Microfluidics is able to achieve superior cell disruption results, read our article: https://hubs.la/Q02zMlc00 #Microfluidizer #Microfluidics #celldisruptionproduction #celllyse #cellrupture #Microfluidizerprocessors #highshearprocessors

🔬💡 𝘈𝘳𝘦 𝘺𝘰𝘶 𝘢  𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫 𝐨𝐟 𝐞𝐱𝐭𝐫𝐚𝐜𝐭𝐢𝐨𝐧 𝐤𝐢𝐭𝐬 𝐨𝐫 𝐏𝐂𝐑 𝐤𝐢𝐭𝐬 𝘭𝘰𝘰𝘬𝘪𝘯𝘨 𝘵𝘰 𝘦𝘯𝘩𝘢𝘯𝘤𝘦 𝘵𝘩𝘦 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘤𝘺 𝘢𝘯𝘥 𝘢𝘶𝘵𝘰𝘮𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘺𝘰𝘶𝘳 𝘸𝘰𝘳𝘬𝘧𝘭𝘰𝘸𝘴? Introducing 𝐂𝐡𝐫𝐨𝐦𝐚 𝐌𝐚𝐠𝐗𝐭𝐫𝐚𝐜𝐭® 3200, 𝐚𝐧 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐧𝐮𝐜𝐥𝐢𝐞𝐜 𝐚𝐜𝐢𝐝 𝐞𝐱𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐏𝐂𝐑 𝐬𝐞𝐭𝐮𝐩 𝐬𝐲𝐬𝐭𝐞𝐦- the ultimate open platform for extration and PCR prep integration. ✨ 𝐒𝐞𝐚𝐦𝐥𝐞𝐬𝐬𝐥𝐲 𝐜𝐨𝐦𝐛𝐢𝐧𝐞 𝐲𝐨𝐮𝐫 𝐞𝐱𝐭𝐫𝐚𝐜𝐭𝐢𝐨𝐧 𝐨𝐫 𝐏𝐂𝐑 𝐤𝐢𝐭𝐬 𝐰𝐢𝐭𝐡 𝐌𝐚𝐠𝐗𝐭𝐫𝐚𝐜𝐭® 3200 to streamline your laboratory processes. Our open platform design supports various brands of kits, ensuring compatibility and flexibility for your specific needs. ⏱️ 𝐒𝐚𝐲 𝐠𝐨𝐨𝐝𝐛𝐲𝐞 𝐭𝐨 𝐭𝐢𝐦𝐞-𝐜𝐨𝐧𝐬𝐮𝐦𝐢𝐧𝐠 𝐦𝐚𝐧𝐮𝐚𝐥 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰𝐬! By integrating your kits with MagXtract® 3200, you can significantly reduce hands-on time and achieve automation in your laboratory. This allows you to focus on what truly matters - generating high-quality results and accelerating your research or diagnostic workflows. 🧪 Whether you're working in research, clinical diagnostics, or any other molecular biology application, MagXtract® 3200 offers unparalleled versatility and efficiency. From nucleic acid extraction to PCR setup and beyond, our platform is designed to optimize every step of your workflow. 🚀 Join forces with MagXtract® 3200 and take your kit performance to the next level. Contact us today to learn more about how our platform can enhance the capabilities of your extraction or PCR kits. #MolecularDiagnostics #LaboratoryAutomation #ExtractionKits #PCRKits #ChromaMagXtract3200 #Innovation #Research #Diagnostics #Efficiency #Automation

Blood-biomaterial Interaction in #ECMO?? Identifying the proteins that share a commonality among circuits has the potential to target specific cellular pathways to potentially prevent clot burden. Moreover, understanding the location of protein deposition may guide biomaterial engineering & manufacturing to develop new circuits with the goal of decreasing thrombosis formation and protein adsorption. Open access editorial 🔓 https://bit.ly/40zcUea Refers to study aimed to comprehensively characterize surface-bound proteins & to measure thickness of fibrin fibers bound to #ECLS circuit in #PedsICU 🔓 https://bit.ly/3YRFdmS

Why are Microfluidizer® processors preferred by top companies for their cell disruption needs? Our high-yield cell lysis technology is: * Easy to use and requires little maintenance * Fast to process compared to alternative methods * Efficient and results in high yields Microfluidics offers technologies to meet the variable and demanding needs for cell disruption, from gentle disruption of cultured mammalian cells to the challenging disruption of yeast and other fungi. To learn how Microfluidics is able to achieve superior cell disruption results, read our article: https://hubs.la/Q02HXpML0 #Microfluidizer #Microfluidics #celldisruptionproduction #celllyse #cellrupture #Microfluidizerprocessors #highshearprocessors